Gene · 580
Papers4,139
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 4,139
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Germline and somatic variants in ovarian carcinoma: A next-generation sequencing (NGS) analysis. | Front Oncol | 2022 | 36531003 | PubTator, text mining | PubMed |
| In Silico and Structure-Based Assessment of Similar Variants Discovered in Tandem Repeats of BRCT Domains of BRCA1 and BARD1 To Characterize the Folding Pattern. | ACS Omega | 2022 | 36530327 | PubTator, text mining | PubMed |
| Genetic landscape of colorectal cancer patients manifesting tumor shrinkage during SARS-Cov-2 infection. | Ther Adv Med Oncol | 2022 | 36518158 | PubTator, text mining | PubMed |
| Structural variant analysis of a cancer reference cell line sample using multiple sequencing technologies. | Genome Biol | 2022 | 36514120 | PubTator, text mining | PubMed |
| Management of metastatic castration-resistant prostate cancer in Middle East African countries: Challenges and strategic recommendations. | Urol Ann | 2022 | 36505997 | PubTator, text mining | PubMed |
| Nucleosomes and their complexes in the cryoEM era: Trends and limitations. | Front Mol Biosci | 2022 | 36504712 | PubTator, text mining | PubMed |
| DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities. | Int J Mol Sci | 2022 | 36499000 | PubTator, text mining | PubMed |
| Splicing-Disrupting Mutations in Inherited Predisposition to Solid Pediatric Cancer. | Cancers (Basel) | 2022 | 36497448 | PubTator, text mining | PubMed |
| Regulation of RNA Polymerase I Stability and Function. | Cancers (Basel) | 2022 | 36497261 | PubTator, text mining | PubMed |
| Epigenetic Regulation in Chromium-, Nickel- and Cadmium-Induced Carcinogenesis. | Cancers (Basel) | 2022 | 36497250 | PubTator, text mining | PubMed |
| The BRCAness Landscape of Cancer. | Cells | 2022 | 36497135 | PubTator, text mining | PubMed |
IMAGENE trial: multicenter, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy of niraparib with PD-1 inhibitor in solid cancer patients with homologous recombination repair genes mutation. | BMC Cancer | 2022 | 36494792 | PubTator, text mining | PubMed |
| The BRCA1 BRCT promotes antisense RNA production and double-stranded RNA formation to suppress ribosomal R-loops. | Proc Natl Acad Sci U S A | 2022 | 36490315 | PubTator, text mining | PubMed |
| Harnessing immunomodulation during DNA damage in Ewing sarcoma. | Front Oncol | 2022 | 36483025 | PubTator, text mining | PubMed |
| BRCA1 mediates protein homeostasis through the ubiquitination of PERK and IRE1. | iScience | 2022 | 36471805 | PubTator, text mining | PubMed |
| Single cell sequencing revealed the mechanism of PD-1 resistance affected by the expression profile of peripheral blood immune cells in ESCC. | Front Immunol | 2022 | 36466860 | PubTator, text mining | PubMed |
| The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer. | Nat Genet | 2022 | 36456881 | PubTator, text mining | PubMed |
| ECPPF (E2F1, CCNA2, POLE, PPP2R1A, FBXW7) stratification: Profiling high-risk subtypes of histomorphologically low-risk and treatment-insensitive endometrioid endometrial cancer. | PLoS One | 2022 | 36454788 | PubTator, text mining | PubMed |
| Integrating Single-Cell Transcriptome and Network Analysis to Characterize the Therapeutic Response of Chronic Myeloid Leukemia. | Int J Mol Sci | 2022 | 36430822 | PubTator, text mining | PubMed |
| Molecular Management of High-Grade Serous Ovarian Carcinoma. | Int J Mol Sci | 2022 | 36430255 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/580/papers?page=41